搜索筛选:
搜索耗时3.9915秒,为你在为你在102,285,761篇论文里面共找到 3 篇相符的论文内容
发布年度:
Safety Data From KEYNOTE-059 Cohort 2: Pembrolizumab Plus 5-Fluorouracil (5-FU) and Cisplatin for Fi
[会议论文] 作者：Fuchs,Josep Tabernero,Eric Van Cutsem,Jiang Dian Wang,Baohoang Lam,Rita Dalal,Minori Koshiji,Yung-Jue,
来源：第十二届国际胃癌学术会议 年份：2017
...
Analysis of KRAS/NRAS and BRAF Mutations in the Phase 3 PRIME Study of Panitumumab+FOLFOX4 vs.FOLFOX
[会议论文] 作者：Kelly S.Oliner,Jean-Yves Douillard,Salvatore Siena,Josep Tabernero,Ronald Burkes,Mario Barugel,Yves Humblet,
来源：第十六届全国临床肿瘤学大会暨2013年CSCO学术年会 年份：2013
Background: Analysis of a phase 3 panitumumab monotherapy study suggested that KRAS and NRAS mutations beyond KRAS exon 2 may be predictive of panitumumab efficacy (Peeters M,et al.Clin Cancer Res 201...
[会议论文] 作者：Jean-Yves Douillard,Salvatore Siena,Josep Tabernero,Ronald Burkes,Mario Barugel,Yves Humblet,Gyorgy Bodoky,
来源：第十六届全国临床肿瘤学大会暨2013年CSCO学术年会 年份：2013
目的: The primary and final analyses of PRIME demonstrated that panitumumab+FOLFOX4 significantly improved progression-free survival (PFS) vs.FOLFOX4 alone for 1st-line treatment of patients with wild-t...
相关搜索：
